Latest News about Psychedelics
Recent news which mentions Psychedelics
More Protocols And Guidance Are Needed As Momentum Builds For Veterans, Psychedelics, And Mental Health
December 13, 2023
From Benzinga
Jamaica's Rose Hill And ACS Laboratory Join Forces To Develop Rigorous Psilocybin Testing Standards
December 12, 2023
From Benzinga
State-Regulated Psychedelics 'On A Collision Course' With FDA, Says Harvard Law Expert
December 12, 2023
From Benzinga
Could MDMA Revolutionize PTSD Treatment? In Historic Move, FDA Considers New Drug Application
December 12, 2023
From Benzinga
Revolutionizing Global Communications: The Role Of AI In Streamlining The Cannabis And Psychedelic Industries
December 12, 2023
Tickers
TECH
From Benzinga
Merger Alert: Tryp Therapeutics Signs With Australian Drug Delivery Innovator, Details Here
December 11, 2023
From Benzinga
Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
December 11, 2023
From Benzinga
Psychedelics In Mexico: Are They Legal? Well, Yes And No
December 10, 2023
Tickers
DMT
From Benzinga
Coca Leaf Ventures: Mapping Pharma & Nutraceuticals, Value Chain And Investment Opportunities
December 10, 2023
From Benzinga
LSD And Psilocybin Could Outperform Opioids For Pain, Without Developing Tolerance, New Study Says
December 10, 2023
From Benzinga
Bicameral Broad Defense Bill Mandates Psychedelics Clinical Trials For Active Service Members
December 08, 2023
From Benzinga
Coca Leaf, Extract, Cocaine & Safe Supply: Grasping Potentials With Sector Incubator's President Ronan Levy
December 08, 2023
Tickers
ACB
From Benzinga
Chatbot Your Drug Questions And Concerns Away With This New AI Tool
December 08, 2023
From Benzinga
John Lennon's Psychedelic Adventures And His Enduring Legacy
December 08, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.